ReviewPharmaceutics2023
Heterocyclic Molecular Targeted Drugs and Nanomedicines for Cancer: Recent Advances and Challenges.
Junxia Liu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it
ReviewPharmaceutics2023
Junxia Liu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.